Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-018701
Filing Date
2024-06-14
Accepted
2024-06-14 16:16:12
Documents
2
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1369
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 4173
  Complete submission text file 0001127602-24-018701.txt   7207
Mailing Address 10 FINDERNE AVE BRIDGEWATER NJ 08807
Business Address
POTTER MYRTLE S (Reporting) CIK: 0001214130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40097 | Film No.: 241045023

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)